Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FARICIMAB vs FEDRATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FARICIMAB vs FEDRATINIB: Safety Overview

Metric FARICIMAB FEDRATINIB
Total FAERS Reports 381 1,404
Deaths Reported 23 203
Death Rate 6.0% 14.5%
Hospitalizations 98 294
Average Patient Age 69.6 yrs 71.1 yrs
% Female Patients 51.2% 48.7%
FDA Approval Date N/A Aug 16, 2019
Manufacturer Genentech, Inc. Celgene Corporation
Route INTRAVITREAL ORAL
Marketing Status N/A Prescription